Literature DB >> 12953043

Secondary minimal change disease.

Richard J Glassock1.   

Abstract

The great majority of patients identified as having a 'minimal change lesion' accompanying the nephrotic syndrome have a primary or 'idiopathic' disorder. Nevertheless, it is quite apparent that a similar or identical lesion can appear consequent to a growing number of underlying diseases; it is then known as 'secondary minimal change disease'. The predisposing conditions include neoplastic diseases, toxic or allergic reactions to drugs, infections, auto-immune disorders and other miscellaneous entities. These disorders are reviewed and catalogued in this contribution.

Entities:  

Mesh:

Year:  2003        PMID: 12953043     DOI: 10.1093/ndt/gfg1060

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  22 in total

1.  A young woman with oedema.

Authors:  Elena Lazzeri; Giuseppe Stefano Netti; Benedetta Mazzinghi; Calogero Cirami; Maurizio Salvadori; Paola Romagnani
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

2.  Development of minimal-change glomerular disease and Hashimoto's thyroiditis during the treatment of sarcoidosis.

Authors:  Fumiaki Ando; Tomokazu Okado; Eisei Sohara; Tatemitsu Rai; Shinichi Uchida; Sei Sasaki
Journal:  CEN Case Rep       Date:  2013-03-17

Review 3.  [Minimal change disease and focal segmental glomerulosclerosis].

Authors:  J Müller-Deile; H Schenk; M Schiffer
Journal:  Internist (Berl)       Date:  2019-05       Impact factor: 0.743

4.  Antimalarial Drugs for the Prevention of Chronic Kidney Disease in Patients with Rheumatoid Arthritis: The Importance of Controlling Chronic Inflammation?

Authors:  Jennifer C Rodrigues; Joanne M Bargman
Journal:  Clin J Am Soc Nephrol       Date:  2018-04-16       Impact factor: 8.237

5.  Lymphoepithelioma-like thymic carcinoma in a 16-year-old boy with nephrotic syndrome--a case report.

Authors:  Katarzyna Kiliś-Pstrusińska; Anna Medyńska; Danuta Zwolińska; Grzegorz Dobaczewski
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

6.  Minimal Change Disease as a Secondary and Reversible Event of a Renal Transplant Case with Systemic Lupus Erythematosus.

Authors:  Elena Gkrouzman; Kyriakos A Kirou; Surya V Seshan; James M Chevalier
Journal:  Case Rep Nephrol       Date:  2015-08-13

7.  Clarithromycin-induced acute interstitial nephritis and minimal change disease.

Authors:  Wendy Russell; William Smith
Journal:  NDT Plus       Date:  2009-07-03

8.  Rifampicin-induced minimal change disease is improved after cessation of rifampicin without steroid therapy.

Authors:  Dong Hyuk Park; Sul A Lee; Hyeon Joo Jeong; Tae-Hyun Yoo; Shin-Wook Kang; Hyung Jung Oh
Journal:  Yonsei Med J       Date:  2015-03       Impact factor: 2.759

9.  Ibuprofen-associated minimal change disease and acute interstitial nephritis with possibly linked membranous glomerulonephritis.

Authors:  Andrew C Liu; Yongen Chang; Jonathan E Zuckerman; Kamyar Kalantar-Zadeh; Lena M Ghobry; Ramy M Hanna
Journal:  SAGE Open Med Case Rep       Date:  2021-06-21

10.  Minimal change nephrotic syndrome showing complete remission after resection of a neurofibroma in a type I neurofibromatosis patient.

Authors:  Ji In Hyun; Ji Won Min; Hye Min Lee; Yong Kyun Kim; Eu Jin Choi; Ho Cheol Song
Journal:  Korean J Intern Med       Date:  2016-03-08       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.